|
Market Closed -
Australian S.E.
00:49:12 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.0600 AUD | 0.00% |
|
0.00% | -29.41% |
| 04-21 | Global health posts customer receipts of A$1,847k for 3 months | RE |
| 02-25 | Global Health Limited Reports Earnings Results for the Half Year Ended December 31, 2025 | CI |
| Market Cap | 3.53M 2.53M 2.17M 2.03M 1.86M 3.48M 242M 23.94M 9.34M 122M 9.49M 9.29M 402M | P/E 2024 |
-5.31x | P/E 2025 | -4.56x |
|---|---|---|---|---|---|
| Enterprise Value | 3.61M 2.58M 2.21M 2.07M 1.9M 3.56M 247M 24.47M 9.54M 124M 9.7M 9.49M 411M | EV / Sales 2024 |
0.68x | EV / Sales 2025 | 0.47x |
| Free-Float |
34.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -7.69% | ||
| 1 month | -7.69% | ||
| 3 months | -1.64% | ||
| 6 months | -18.92% | ||
| Current year | -29.41% |
| 1 week | 0.06 | 0.06 | |
| 1 month | 0.06 | 0.07 | |
| Current year | 0.05 | 0.09 | |
| 1 year | 0.05 | 0.14 | |
| 3 years | 0.05 | 0.17 | |
| 5 years | 0.05 | 0.5 | |
| 10 years | 0.05 | 0.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 68 | 2022-11-16 | |
Damon Groenveld
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chris Fernandes
SEC | Corporate Secretary | - | 2025-11-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 2004-12-31 | |
Grant Smith
CHM | Chairman | 72 | 2021-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -45.45% | -60.00% | 2.53M | ||
| -1.05% | +1.70% | -14.77% | +32.38% | 40.27B | ||
| -6.99% | +7.12% | -37.47% | +163.44% | 14.35B | ||
| -1.35% | -1.84% | -21.60% | +60.88% | 5.66B | ||
| +6.30% | +18.23% | +70.58% | - | 4.33B | ||
| +0.81% | +3.07% | - | - | 2.07B | ||
| +0.23% | -4.61% | +5.83% | -38.24% | 1.62B | ||
| -3.58% | +22.15% | -29.55% | - | 1.18B | ||
| +9.22% | +11.56% | +45.13% | +154.15% | 1.03B | ||
| +2.88% | -2.05% | +49.48% | +58.81% | 1.03B | ||
| Average | +0.65% | +4.78% | +2.46% | +53.06% | 7.15B | |
| Weighted average by Cap. | -1.58% | +3.83% | -12.63% | +64.89% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.66M 6.21M 5.32M 4.97M 4.55M 8.55M 594M 58.77M 22.92M 298M 23.3M 22.8M 987M | 8.67M 6.21M 5.32M 4.98M 4.56M 8.55M 594M 58.82M 22.94M 299M 23.32M 22.82M 987M |
| Net income | -1.31M -941K -806K -754K -690K -1.3M -89.99M -8.91M -3.47M -45.2M -3.53M -3.45M -150M | -867K -621K -532K -498K -456K -855K -59.44M -5.88M -2.29M -29.86M -2.33M -2.28M -98.76M |
| Net Debt | -1.04M -745K -638K -597K -547K -1.03M -71.28M -7.05M -2.75M -35.81M -2.8M -2.74M -118M | 77.75K 55.73K 47.74K 44.67K 40.89K 76.73K 5.33M 528K 206K 2.68M 209K 205K 8.86M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | A$0.0600 | 0.00% | 105,635 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GLH Stock
Select your edition
All financial news and data tailored to specific country editions
















